Interaction of an artificial surfactant in human pulmonary epithelial cells

Pediatric Pulmonology

Volumn 39, Issue 2, 2005, Pages 167-177

  Romero, Edgar J ^a   Moya, Fernando R ^a   Tuvim, Michael J ^b   Alcorn, Joseph L ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

KL4; RDS; SP B; Surfactant; Surfaxin ; Type II cells

Indexed keywords

BREFELDIN A; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; LUNG SURFACTANT; SINAPULTIDE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; EPITHELIUM CELL; FETUS; HUMAN; HUMAN CELL; LAMELLAR BODY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; MICROSCOPY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ADENOCARCINOMA; BLOTTING, NORTHERN; BREFELDIN A; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DRUG COMBINATIONS; EXOCYTOSIS; HUMANS; INTRACELLULAR FLUID; LUNG NEOPLASMS; MICROSCOPY, ELECTRON; ORGANELLES; PEPTIDES; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; PULMONARY ALVEOLI; RESPIRATORY MUCOSA; RNA, MESSENGER;

EID: 13444301096     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20166     Document Type: Article

References (44)

1. Odom MW, Ballard PL. Developmental and hormonal regulation of the surfactant system. In: McDonald JA, editor. Lung growth and development. New York: Marcel Dekker, Inc.; 1997.
2. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-523.
3. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991;254:566-568.
4. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92:7794-7798.
5. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:1860-1863.
6. Robertson B, Halliday HL. Principles of surfactant replacement. Biochim Biophys Acta 1998;1408:346-361.
7. Halliday HL, Speer CP. Strategies for surfactant therapy in established neonatal respiratory distress syndrome. In: Taeusch HW, editor. Surfactant therapy for lung disease. Volume 84, lung biology in health and disease. New York: Marcel Dekker, Inc.; 1995. p 443-459.
8. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. J Pediatr 1991;118:277-284.
9. Egberts J, de Winter JP, Sedin G, de Kleine MJ, Broberger U, van Bel F, Curstedt T, Robertson B. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics 1993;92:768-774.
10. Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, Easa D, Pramanik A, LeBlanc M, Anday E, et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I. J Pediatr 1992;120:3-12.
11. Walther FJ, Hernandez-Juviel J, Bruni R, Waring AJ. Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats. Am J Respir Crit Care Med 1997;156: 855-861.
12. Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr Res 1991;29:460-465.
13. Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 1996;39: 715-724.
14. Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:404-410.
15. Ohashi T, Polk D, Ikegami M, Ueda T, Jobe A. Ontogeny and effects of exogenous surfactant treatment on SP-A, SP-B, and SP-C mRNA expression in rabbit lungs. Am J Physiol 1994;267: 46-51.
16. Amato M, Petit K, Fiore HH, Doyle CA, Frantz ID III, Nielsen HC. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung. Pediatr Res 2003;53:671-678.
17. Alcorn JL, Smith ME, Smith JF, Margraf LR, Mendelson CR. Primary cell culture of human type II pneumonocytes: maintenance of a differentiated phenotype and transfection with recombinant adenoviruses. Am J Respir Cell Mol Biol 1997;17: 672-682.
18. O'Reilly MA, Gazdar AF, Clark JC, Pilot-Matias TJ, Wert SE, Hull WM, Whitsett JA. Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line. Am J Physiol 1989;257:385-392.
19. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976; 17:62-70.
20. Sano K, Voelker DR, Mason RJ. Effect of secretagogues on cytoplasmic free calcium in alveolar type II epithelial cells. Am J Physiol 1987;253:679-686.
21. Misumi Y, Miki K, Takatsuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 1986;261: 11398-11403.
22. Evans WH. Isolation and characterization of membranes and cell organelles. In: Rickwood D, editor. Preparative centrifugation: a practical approach. Oxford: IRL Press; 1992. p 233-270.
23. Mason RJ, Walker SR, Shields BA, Henson JE, Williams MC. Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain. Am Rev Respir Dis 1985;131:786-788.
24. Griese M, Beck J, Feuerhake F. Surfactant lipid uptake and metabolism by neonatal and adult type II pneumocytes. Am J Physiol 1999;277:901-909.
25. Bates SR, Fisher AB. Degradation of surfactant protein B by alveolar type II cells. Am J Physiol 1993;265:448-455.
26. Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis 1987;136:426-444.
27. Wright JR. Clearance and recycling of pulmonary surfactant. Am J Physiol 1990;259:1-12.
28. Johnson AL, Braidotti P, Pietra GG, Russo SJ, Kabore A, Wang WJ, Beers MF. Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments. Am J Respir Cell Mol Biol 2001;24:253-263.
29. Wiswell TE, Smith RM, Katz LB, Mastroianni L, Wong DY, Willms D, Heard S, Wilson M, Hite RD, Anzueto A, Revak SD, Cochrane CG. Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;160:1188-1195.
30. Breslin JS, Weaver TE. Binding, uptake, and localization of surfactant protein B in isolated rat alveolar type II cells. Am J Physiol 1992;262:699-707.
31. Bates SR, Beers MF, Fisher AB. Binding and uptake of surfactant protein B by alveolar type II cells. Am J Physiol 1992;263:333-341.
32. Ashton MR, Postle AD, Hall MA, Austin NC, Smith DE, Normand IC. Turnover of exogenous artificial surfactant. Arch Dis Child 1992;67:383-387.
33. Hallman M, Merritt TA, Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin Pharmacokinet 1994;26:215-232.
34. Ikegami M, Jobe AH. Surfactant metabolism. Semin Perinatol 1993;17:233-240.
35. Alberti A, Pettenazzo A, Enzi GB, Palamidese A, Mapp C, Ventura P, Baritussio A. Uptake and degradation of Curosurf after tracheal administration to newborn and adult rabbits. Eur Respir J 1998;12:294-300.
36. Oetomo SB, Lewis J, Ikegami M, Jobe AH. Surfactant treatments alter endogenous surfactant metabolism in rabbit lungs. J Appl Physiol 1990;68:1590-1596.
37. Ikegami M, Jobe A, Yamada T, Priestly A, Ruffini L, Rider E, Seidner S. Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol 1989;67:429-437.
38. Rider ED, Ikegami M, Jobe AH. Localization of alveolar surfactant clearance in rabbit lung cells. Am J Physiol 1992; 263:201-209.
39. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 1986;46: 798-806.
40. Ikegami M, Jobe AH. Surfactant protein-C in ventilated premature lamb lung. Pediatr Res 1998;44:860-864.
41. Ikegami M, Horowitz AD, Whitsett JA, Jobe AH. Clearance of SP-C and recombinant SP-C in vivo and in vitro. Am J Physiol 1998;274:933-939.
42. Rooney SA. Regulation of surfactant secretion. Comp Biochem Physiol [A] 2001;129:233-243.
43. Hallman M, Lappalainen U, Bry K. Clearance of intra-amniotic lung surfactant: uptake and utilization by the fetal rabbit lung. Am J Physiol 1997;273:55-63.
44. Pinkerton KE, Ikegami M, Dillard LM, Jobe AH. Surfactant treatment effects on lung structure and type II cells of preterm ventilated lambs. Biol Neonate 2000;77:243-252.